12 Health Care Stocks Moving In Monday's After-Market Session

Gainers

  • Agape ATP ATPC shares rose 23.0% to $0.32 during Monday's after-market session. The market value of their outstanding shares is at $24.9 million.
  • FibroGen FGEN shares increased by 20.68% to $1.4. The market value of their outstanding shares is at $139.2 million. As per the news, the Q1 earnings report came out today.
  • RxSight RXST shares rose 11.39% to $70.0. The company's market cap stands at $2.6 billion. As per the news, the Q1 earnings report came out today.
  • Innovative Eyewear LUCY shares increased by 10.81% to $0.25. The market value of their outstanding shares is at $3.2 million.
  • Hims & Hers Health HIMS shares increased by 10.72% to $12.9. The company's market cap stands at $2.7 billion. As per the press release, Q1 earnings came out today.
  • iSpecimen ISPC stock increased by 8.58% to $0.3. The company's market cap stands at $2.7 million.

Losers

  • Predictive Oncology POAI shares decreased by 9.1% to $1.6 during Monday's after-market session. The market value of their outstanding shares is at $6.5 million.
  • SI-BONE SIBN shares fell 6.77% to $13.5. The company's market cap stands at $556.2 million. As per the news, the Q1 earnings report came out today.
  • Anitra AZTR stock fell 5.68% to $0.25. The company's market cap stands at $7.2 million.
  • Ontrak OTRK stock declined by 5.28% to $0.24. The market value of their outstanding shares is at $11.2 million.
  • Clene CLNN shares declined by 5.15% to $0.4. The company's market cap stands at $51.6 million.
  • Regulus Therapeutics RGLS shares fell 4.96% to $2.3. The market value of their outstanding shares is at $150.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!